ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Insufficient Data To Prove Digital Mammograms Better, Michigan Consortium Finds

August 29, 2003

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

Frist Backs Federal Funding For Stem Cell Research.

July 20, 2001

In Brief: Surgeons Oncology Group Gets NCI Funding To Conduct Multicenter Clinical Trials

April 17, 1998

AACI Leaders Regret “Unfortunate Rhetoric,” Pledge Support To Broder

August 11, 1989

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010